期刊文献+

甲状旁腺激素调控人成骨样细胞膜型基质金属蛋白酶-1表达 被引量:7

Parathyroid hormone inhibits the expression of membrane-type matrix metalloproteinase-1 in osteoblast-like MG-63 cells
原文传递
导出
摘要 目的 探讨甲状旁腺激素 (PTH)对人成骨样MG 6 3细胞膜型基质金属蛋白酶 1(MT1 MMP)表达的影响及调节骨代谢作用的机制。 方法 用PTH(1 34)干预MG 6 3细胞培养 ,Northern杂交及Western杂交检测MT1 MMPmRNA与蛋白质表达水平。 结果 PTH (1 34) 10 9mmol/L~ 10 7mmol/L浓度对MG 6 3细胞MT1 MMPmRNA及蛋白质表达有抑制作用 ,并呈剂量依赖性。 10 8mmol/L干预在 2~ 4 8h内对抑制MT1 MMPmRNA及蛋白质表达抑制有时间依赖性。蛋白激酶A(PKA)抑制剂H 89阻断PTH(1 34)抑制MT1 MMP表达的效应 ,而蛋白激酶A(PKA)激动剂Forskolin抑制MT1 MMP表达。 结论 PTH具有抑制成骨样细胞MT1 MMP表达的作用 ,其作用途径可能有PKA信号转导途径参与。 Objective To study the effects of parathyroid hormone (PTH) on the expression of membrane-type matrix metalloproteinase-1 (MT1-MMP) in human osteoblast-like cell line MG-63 and to understand the mechanism by which PTH exerts on bone. Methods MG-63 cells were treated with PTH(1-34). Northern blot, Western blot was used respectively to analyze the PTH(1-34) effect on expression level of MT1-MMP mRNA and protein of MG-63 cells. Results PTH(1-34) inhibited MT1-MMP mRNA levels in a dose-dependent manner in MG-63 cells. After 24-48 h of treatment, 10 -8 mmol/L of PTH (1-34) inhibited MT1-MMP mRNA expression. PTH(1-34) inhibited MT1-MMP protein levels in a dose-dependent manner in MG-63 cells. After 24-48 h of treatment, 10 -8 mmol/L of PTH (1-34) inhibited MT1-MMP protein expression. The PKA antagonist H-89 blunted PTH(1-34)-mediated decreases in MT1-MMP protein synthesis. Forskolin, a PKA agonist, decresed MT1-MMP expression. Conclusions PTH may stimulate bone resorption by decreasing MT1-MMP production in osteoblast-like cells. PTH(1-34) inhibites MT1-MMP expression via the PKA pathway in MG-63 cells.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2004年第1期5-8,共4页 Chinese Journal of Geriatrics
基金 国家自然科学基金资助项目 (3 0 2 0 0 3 2 2 ) 全国优秀博士学位论文作者专项资金项目 (2 0 0 2 5 9)
关键词 甲状旁腺激素 成骨样细胞 基质金属蛋白酶-1 骨代谢 细胞培养 信号转导 Parathyroid hormones Osteoblast Metallo endopeptidases
  • 相关文献

参考文献8

  • 1Lajeunesse D,Kiebzak GM,Frondoza C,et al.Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63[].Bone and Mineral.1991
  • 2D,Ortho MP,Will H,Atklnson S,et al.Membrane-type matrix metalloproteinase 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases[].European Journal of Biochemistry.1997
  • 3Lajeunesse D,Frondoza C,Schoffield B,et al.Osteocalcin secretion by the human osteosarcoma cell line MG-63[].Journal of Bone and Mineral Research.1990
  • 4Luo XH,Liao EY.Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 ( MT1-MMP )compartment of proMMP-2 activation in MG-63 cells[].Hormone and Metabolic Research.2001
  • 5Azuma Y,Kaji K,Katogi R,et al.Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts[].Journal of Biological Chemistry.2000
  • 6Birch MA,Skerry TM.Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones[].Bone.1999
  • 7Li W,Farach-Carson MC.Parathyroid hormone-stimulated resorption in calvaria cultured in serum-free medium is enhanced by the calcium-mobilizing activity of 1, 25-dihydroxyvitamin D ( 3 )[].Bone.2001
  • 8Westermarck J,Kahari VM.Regulation of matrix metalloproteinase expression in tumor invasion[].The FASEB Journal.1999

同被引文献21

  • 1张红,罗湘杭,谢辉,伍贤平,单鹏飞,曹行之,廖二元.基质金属蛋白酶-1、-2与女性年龄、骨转换生化指标及骨密度的关系[J].中华内科杂志,2006,45(4):306-309. 被引量:31
  • 2胡建明,吴宏飞,王笑云,俞香宝,赵奕华,沈霞,刘佳,孙彬,邢昌赢,杨俊伟.肾性甲状旁腺功能亢进症甲状旁腺全切加前臂移植31例临床分析[J].中华内科杂志,2006,45(9):714-716. 被引量:28
  • 3Peters DG, Kassam A, St Jean PL, et al. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potenllal risk factor for intracranial aneurysm [ J ].Stroke, 1999, 30: 2612-2616.
  • 4Gaetani P, Rodriguez Y, Baena R, et al. Metalloproteases and inlracranial vascular lesions[J]. Neurol Res, 1999,21 : 385 - 390.
  • 5Bruno G, Todor R , Lewis I , et al . Vascular extracellular matrix remodeling in cerebral aneurysms[J]. J Neurosurg, 1998, 89: 431- 440.
  • 6Kim S , Singh M, Huang J , et al . Matrix metalloproteinase-9 in cerebral aneurysms[J]. Neurosurgery, 1997,41: 642-647.
  • 7Romanic AM, White RF, Arleth AJ , et al . Matrix metalloproteinase expression increases after cerebral focal ischemia in rats. Inhibition of matrix metalloproteinase-9 reduces infarct size [ J ]. Stroke , 1998 , 29 : 1020 -1030.
  • 8Todor DR, Lewis I, Bruno G, et al. Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as promatrix metalloproteinase-2[J].Stroke, 1998, 29: 1580-1583.
  • 9AAssar OS, Fujiwara NH, Marx WF, et al. Aneurysm growth, elasfinolysis, and attempted doxycycline inhibition of elastase-induced aneurysms in rabbits[J]. J Vasc Interv Radiol, 2003. 14: 1427- 1432.
  • 10DAI Yi SHEN Lin.Relationships between serum osteoprotegerin,matrix metalloproteinase-2 levels and bone metabolism in postmenopausal women[J].Chinese Medical Journal,2007(22):2017-2021. 被引量:12

引证文献7

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部